Reference

·

Primary source

BOI Section 8 Medical-Tourism Premium Tier: 0% Duty on Longevity Equipment

0% import duty on HBOT, plasmapheresis, body composition; CIT holiday up to 8 years

As ofFY2024-FY2027 incentive window·Sources3·Primary

The Thailand Board of Investment Targeted Industries A4 Section 8 schedule (medical and wellness tourism premium tier) grants 0 percent import duty on hyperbaric oxygen therapy (HBOT) chambers, plasmapheresis and therapeutic plasma exchange machines, body composition analysers (DEXA, InBody) and full-genome sequencing instruments. The compounding effect with the medical-device-manufacturing incentive shaves roughly 18 to 24 percent off the all-in equipment capex bill for a hospital-owned longevity wing. Bumrungrad VitalLife, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit and BNH have all secured Section 8 certificates for FY2025 to FY2027 equipment procurement. Resort-cluster longevity retreats are slower to certify because the resort-operator vehicle is not always the importer of record; the 2027 catalyst is co-certification with a Bangkok hospital partner.

Figure in context

The Thailand Board of Investment Targeted Industries A4 Section 8 schedule (medical and wellness tourism premium tier) grants 0 percent import duty on hyperbaric oxygen therapy (HBOT) chambers, plasmapheresis and therapeutic plasma exchange machines, body composition analysers (DEXA, InBody) and full-genome sequencing instruments. The compounding effect with the medical-device-manufacturing incentive shaves roughly 18 to 24 percent off the all-in equipment capex bill for a hospital-owned longevity wing. Bumrungrad VitalLife, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit and BNH have all secured Section 8 certificates for FY2025 to FY2027 equipment procurement. Resort-cluster longevity retreats are slower to certify because the resort-operator vehicle is not always the importer of record; the 2027 catalyst is co-certification with a Bangkok hospital partner.

The Thailand Board of Investment Targeted Industries A4 Section 8 schedule (medical and wellness tourism premium tier) grants 0 percent import duty on hyperbaric oxygen therapy (HBOT) chambers, plasmapheresis and therapeutic plasma exchange machines, body composition analysers (DEXA, InBody) and full-genome sequencing instruments. The compounding effect with the medical-device-manufacturing incentive shaves roughly 18 to 24 percent off the all-in equipment capex bill for a hospital-owned longevity wing. Bumrungrad VitalLife, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit and BNH have all secured Section 8 certificates for FY2025 to FY2027 equipment procurement. Resort-cluster longevity retreats are slower to certify because the resort-operator vehicle is not always the importer of record; the 2027 catalyst is co-certification with a Bangkok hospital partner.

Time scope

FY2024-FY2027 incentive window

Source basis

Primary source

Interpretation notes

What this tells you

The Thailand Board of Investment Targeted Industries A4 Section 8 schedule (medical and wellness tourism premium tier) grants 0 percent import duty on hyperbaric oxygen therapy (HBOT) chambers, plasmapheresis and therapeutic plasma exchange machines, body composition analysers (DEXA, InBody) and full-genome sequencing instruments. The compounding effect with the medical-device-manufacturing incentive shaves roughly 18 to 24 percent off the all-in equipment capex bill for a hospital-owned longevity wing. Bumrungrad VitalLife, BDMS Bangkok Hospital Longevity Center, Samitivej Sukhumvit and BNH have all secured Section 8 certificates for FY2025 to FY2027 equipment procurement. Resort-cluster longevity retreats are slower to certify because the resort-operator vehicle is not always the importer of record; the 2027 catalyst is co-certification with a Bangkok hospital partner.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

2027 forecast
USD 0.8-1.5B by 2027 (vs USD 0.18-0.3B 2024)

Thailand Longevity-Medicine Clinic Tourism Market Size

Insight derivation from Bumrungrad Form 56-1 FY2024, BDMS Form 56-1 FY2024, TAT Medical Wellness Strategic Plan 2023-2027, IMARC Global Longevity 2024, retreat resort tariff disclosures

FY2026-FY2027 list pricing
USD 8,000-22,000 per visit (median ~USD 12,500)

Thailand Longevity-Clinic 3-5 Day Package Average Selling Price

Bumrungrad VitalLife clinic tariff 2025, Samitivej Longevity Center programme menu 2025, BNH Wellness Center menu 2025, Bangkok Hospital Longevity Center brochure 2026

FY2026-FY2027 published tariff
USD 35,000-65,000 per person (Aman Puri premium tops USD 65,000)

Phuket Wellness Resort 14-Day Longevity Retreat Average Selling Price

Banyan Tree Wellbeing Sanctuary tariff 2025, Aman Puri Wellness Immersion brochure 2025, Six Senses Yao Noi wellness menu 2025, Insight derivation

Effective Q1 2027
Compounding-pharmacy registration; off-label-by-protocol clinical use

Thai FDA Clinical Longevity Protocol Framework: Q1 2027 Effect Date

Thai FDA Notification B.E. 2569, Thai Medical Council off-label preventive medicine guideline 2024, MoPH briefing materials

FY2026-FY2027 inbound mix
Hong Kong 22%, Singapore 17%, Middle East 18%, US/AU/EU 28%, Thai domestic 15%

Thailand Longevity-Clinic Inbound Buyer Origin Mix

TCEB Wellness Tourism Report 2026 buyer-profile annex, Bumrungrad Form 56-1 FY2024 international-patient mix disclosure, Insight derivation

FY2024-FY2027 cohort build
~50,000 Thai whole-genome records (target 100,000 by end-2027)

Genomics Thailand Cohort: 50,000-Person Whole-Genome Substrate for Clinical Longevity

NSTDA Genomics Thailand Initiative cohort progress report December 2025, Bumrungrad VitalLife genomic-medicine programme materials

Report context

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

BOI Section 8 Medical-Tourism Premium Tier: 0% Duty on Longevity Equipment · Insight